Lacoxa 15mg Syrup contains lacosamide, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Each 5ml of syrup delivers 15mg of lacosamide, facilitating precise dosing suitable for pediatric and adult patients who require an oral liquid formulation. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes, and inhibiting repetitive neuronal firing, thereby reducing seizure frequency and severity. Lacoxa 15mg Syrup is typically administered as adjunctive therapy in patients inadequately controlled on other antiepileptic drugs or as monotherapy where appropriate. The syrup formulation improves compliance in patients with swallowing difficulties or those requiring dose adjustments. Common adverse effects may include dizziness, headache, nausea, and diplopia, with serious reactions being rare but warranting medical attention. Dosage should be individualized based on clinical response and tolerability, with gradual titration recommended to minimize side effects. Lacoxa 15mg Syrup should be used under strict medical supervision, with regular monitoring of neurological status and potential drug interactions. It is contraindicated in patients with known hypersensitivity to lacosamide or any excipients. Caution is advised in patients with cardiac conduction abnormalities due to potential PR interval prolongation.